By Lindsay Antaya
One of the biggest events for the Commonwealth’s healthcare sector took place on November 12th: the annual Massachusetts Health Policy Commission’s Cost Trends Hearing.
Throughout the day, industry executives, advocates, and community and business leaders testified on the state of healthcare in Massachusetts and highlighted the biggest challenges facing providers, payers, and most importantly, patients.
Here are three key takeaways from the event.
Healthcare is in a Precarious Position
While our state has long been a national leader in medical access and innovation, each panel underscored the difficult reality facing Massachusetts’ healthcare ecosystem.
The first panel of the day brought together community leaders, clinicians, and employers to discuss their experiences with medical care. The discussion painted a vivid picture of a system under significant strain and highlighted the impact these challenges have on Massachusetts.
Several panelists described a primary care system that is weakening and emphasized that investing in the field and attracting new talent is fundamental to improving the overall healthcare system.
Small business owner Neil Abramson of ECI Stores also noted how increasingly expensive healthcare has become, and how cost and access challenges are causing many people to put off necessary care. Frontline clinicians echoed these concerns and pointed out how the strain on providers from increasing administrative burdens is making it difficult to maintain high-quality care.
The panel neatly laid out the situation we find ourselves in currently: Massachusetts needs a more sustainable, equitable healthcare system that meets patients where they are, supports frontline clinicians, and eases the pressure on a workforce already stretched thin.
The Local Impact of Federal Actions
Audrey Shelto, President and CEO of the Blue Cross Blue Shield of Massachusetts Foundation, presented a sobering analysis of the federal One Big Beautiful Bill Act and its potential effects on Massachusetts healthcare. The bill introduces new Medicaid work requirements and more frequent eligibility redeterminations, which will create administrative hurdles for people trying to stay enrolled and could lead to a more than 50 percent increase in the state’s uninsured population.
Shelto began with an important reminder: one in four Massachusetts residents rely on MassHealth, and most people in the Commonwealth know someone who has depended on the program. She noted that while we often talk about enrollment numbers and projections, it is easy to become numb to statistics. That’s why it’s essential to focus on the people behind the data. Shelto shared the impactful story of a mother who left her job as a school bus driver to care for her son with autism and complex medical needs. Because both qualify for MassHealth, her son receives the specialized services that support his independence, and she can access the care that allows her to stay healthy enough to remain his primary caregiver.
Shelto went on to highlight how the federal legislation will ripple across the state, affecting both patients and the broader Massachusetts economy. Despite these risks, she emphasized that Massachusetts is uniquely positioned to respond with bold, collaborative solutions. Leaders on subsequent panels echoed this perspective, outlining potential strategies to protect coverage and access amid federal policy uncertainty, including scaling successful programs, leveraging partnerships, and investing in initiatives that directly support patients.
Balancing Innovation with What is Realistic
A major theme across multiple panels was the need to balance innovation with pragmatism. Massachusetts is known for its healthcare innovation but rising costs and fiscal uncertainty make it essential to prioritize programs that deliver the greatest and most immediate value for patients.
In the pharmaceutical space, speakers stressed that breakthrough treatments must be matched with strategies that keep them sustainable and within reach. Rising drug costs –particularly for GLP-1s and other specialty medications – are putting pressure on employer plans, public programs, and patients, underscoring the need for thoughtful guardrails that preserve innovation without destabilizing the system.
The final panel of the day, comprised of CEOs from hospitals and insurers, highlighted this tension. Kevin Tabb, President and CEO of Beth Israel Lahey Health, urged the system to move beyond “magical thinking,” cautioning against the belief that we can provide more care while putting less money into the system. He noted the duplication of services throughout the state and stressed the need for tough conversations about which services are sustainable, where they should be provided, and how the system can optimize resources while continuing to serve patients.
Final Thoughts
The 2025 Cost Trends Hearing focused heavily on the complex, interconnected challenges facing Massachusetts healthcare. Encouragingly, panelists and commissioners repeatedly emphasized that despite these pressures, they were grateful to be tackling these issues in Massachusetts, a state with a long, proven track record of innovation and collaborative problem-solving. The sector’s history of resilience, partnership, and patient-centered thinking uniquely positions the Commonwealth to navigate federal changes and shape a more equitable healthcare system that works for everyone.